dpp-4 and glp-1 inhibitors GLP-1RAs: cardiovascular safety and benefits | Military Medical Research DPP-4 inhibitors and GLP-1RAs: cardiovascular

By incorporating Akkermansia into your daily routine, youre supporting your bodys natural ability to regulate the production of GLP-1, a key hormone for controlling appetite and digestion

2023 May 23;14:1181913

Metabolic Health Concerns

2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

For U.S